Brainstorm Cell Therapeutics Inc.
BCLI· OTC
BCLIBrainstorm Cell Therapeutics Inc.
Filed May 10, 2019 · 10-Q · 40 days after period end · 0001144204-19-025310
| Metric | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 |
|---|---|---|---|---|
| Net Income | -$5.03M | -$2.30M | -$1.79M | -$1.79M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Brainstorm Cell Therapeutics Inc. · CIK 1137883 · Engraved from SEC EDGAR
ended Mar 31, 2019 · filed May 10, 2019 · 40 d after period end
